God is our Guide                 Number 1 site for helping reverse diseases on Planet Earth
cidpUSA Foundation

 cidpusa.org   

      

 
      Home
      Diagnosis
      Treatment
      Pathology
      Variants
      CIDP info
      Fibromyalgia
      IVIG
      Diet anti-inflammatory
      Burning  Feet Home
      Services Page
      Chronic Fatigue
      Autoimmune diseases
      Prognosis
      Bible healing
      Celiac disease
Bible page

Autoimmunity secrets

Autoimmune inflammation

Autonomic Small Fiber

Myasthenia Holistic

Polymyositis

Dematomyositis

Poly Dermato

Myositis

Inner Ear Disease AIED

 

Risk of heart disease & stroke 

Depression and breast cancer

Kidney stone removal 

Alopecia general

Personality

Eye Clinic

Skin hair nail spa

Memory clinic

Depression & anxiety

Addiction  & Drug Rehab

Sexual  disorders Clinic

Parkinson Clinic

Epilepsy Clinic

Pain Clinic

Bone disorders clinic

Joint disorder clinic

Skin repair clinic

Gene Manipulation

Neurology Clinic

TMJ Clinic

Reduce  your weight

Antibiotics

 Vitiligo

heart disease & stroke 

Memory clinic

Reduce weight

Some rheumatic disorders

oil pulling

 Reading disorders

 Best New Diet

 DHEA Fountain of Youth

Parkinson

Diabetise-2

 www.cidpusa.org/P/ivig.htm

Stop vasculitis

 

Electrical Stimulation Therapy

Addison

Estrogen

DNA

Magnets and l

 

 

 

 Information on immune globulins

  alternatives treatment of autoimmune disease read our e-book 

Immunoglobulins (Ig)

ab0b.gif (9122 bytes)  Figure 2B
Click on the image at left for an animated tutorial on antibody structure 
Requires  Chime Plug-In. Get Chime 

intactab.gif (10350 bytes)  Figur

e 2C Ribbon drawing of the first intact antibody (IgG2A)

 Harris, L. J., Larson, S. B., Hasel, K. W., Day, J., Greenwood, A., McPherson, A. Nature 1992, 360, 369-372. © 2000

  Figure 2D
Rotating antibody
 
Jose Saldanha,  H


Glycoprotein molecules that are produced by plasma cells in response to an immunogen and which function as antibodies. The immunoglobulins derive their name from the finding that they migrate with globular proteins when antibody-containing serum is placed in an electrical field  (Figure 1).

II. GENERAL FUNCTIONS OF IMMUNOGLOBULINS

A. Antigen binding
Immunoglobulins bind specifically to one or a few closely related antigens. Each immunoglobulin actually binds to a specific antigenic determinant. Antigen binding by antibodies is the primary function of antibodies and can result in protection of the host.  The valency of antibody refers to the number of antigenic determinants that an individual antibody molecule can bind. The valency of all antibodies is at least two and in some instances more.

B. Effector Functions
Frequently the binding of an antibody to an antigen has no direct biological effect. Rather, the significant biological effects are a consequence of secondary "effector functions" of antibodies. The immunoglobulins mediate a variety of these effector functions. Usually the ability to carry out a particular effector function requires that the antibody bind to its antigen. Not every immunoglobulin will mediate all effector functions. Such effector functions include:

1. Fixation of complement - This results in lysis of cells and release of biologically active molecules

2. Binding to various cell types - Phagocytic cells, lymphocytes, platelets, mast cells, and basophils have receptors that bind immunoglobulins. This binding can activate the cells to perform some function. Some immunoglobulins also bind to receptors on placental trophoblasts, which results in transfer of the immunoglobulin across the placenta. As a result, the transferred maternal antibodies provide immunity to the fetus and newborn

 

 

stru-2.jpg (119498 bytes)  Figure 2A The basic structure of immunoglobulins

III. BASIC STRUCTURE OF IMMUNOGLOBULINS

The basic structure of the immunoglobulins is illustrated in the Figure 2. Although different immunoglobulins can differ structurally they all are built from the same basic units.

A. Heavy and Light Chains
All immunoglobulins have a four chain structure as their basic unit. They are composed of two identical light chains (23kD) and two identical heavy chains (50-70kD)

B. Disulfide bonds

1. Inter-chain disulfide bonds - The heavy and light chains and the two heavy chains are held together by inter-chain disulfide bonds and by non-covalent interactions The number of inter-chain disulfide bonds varies among different immunoglobulin molecules.

2. Intra-chain disulfide binds - Within each of the polypeptide chains there are also intra-chain disulfide bonds.

C. Variable (V) and Constant (C) Regions
After the amino acid sequences of many different heavy chains and light chains were compared, it became clear that both the heavy and light chain could be divided into two regions based on variability in the amino acid sequences. These are the:

1. Light Chain - VL (110 amino acids) and CL (110 amino acids)

2. Heavy Chain - VH (110 amino acids) and CH (330-440 amino acids)

D. Hinge Region
This is the region at which the arms of the antibody molecule forms a Y. It is called the hinge region because there is some flexibility in the molecule at this point.

E. Domains
Three dimensional  images of the immunoglobulin molecule show that it is not straight as depicted in Figure 2A. Rather, it is folded into globular regions each of which contains an intra-chain disulfide bond (figure 2B-D). These regions are called domains.

1. Light Chain Domains - VL and CL

2. Heavy Chain Domains - VH, CH1 - CH3 (or CH4)

F. Oligosaccharides
Carbohydrates are attached to the CH2 domain in most immunoglobulins. However, in some cases carbohydrates may also be attached at other locations.

 

IV. STRUCTURE OF THE VARIABLE REGION

A. Hypervariable (HVR) or complementarity determining regions (CDR)

Comparisons of the amino acid sequences of the variable regions of immunoglobulins show that most of the variability resides in three regions called the hypervariable regions or the complementarity determining regions as illustrated in Figure 3. Antibodies with different specificities (i.e. different combining sites) have different complementarity determining regions while antibodies of the exact same specificity have identical complementarity determining regions (i.e. CDR is the antibody combining site). Complementarity determining regions are found in both the H and the L chains.

B. Framework regions

The regions between the complementarity determining regions in the variable region are called the framework regions (Figure 3). Based on similarities and differences in the framework regions the immunoglobulin heavy and light chain variable regions can be divided into groups and subgroups. These represent the products of different variable region genes.

stru-3.jpg (100087 bytes)  Figure  3  Structure of the variable region framework regions

ab0b.gif (9122 bytes) Click on image at left to se a rotable molecular structure of an Fab fr hemagglutinin peptide. Requires Chime plug-in. Get Chime here)

ab0b.gif (9122 bytes) Click on image at left to see details of the interaction of a mouse monoclonal antibody interactite lysozyme. Requires Chime plug-in. Get Chime here)

V. IMMUNOGLOBULIN FRAGMENTS: STRUCTURE/FUNCTION RELATIONSHIPS

Immunoglobulin fragments produced by proteolytic digestion have proven very useful in elucidating structure/function relationships in immunoglobulins.

A.  Fab
Digestion with papain breaks the immunoglobulin molecule in the hinge region before the H-H inter-chain disulfide bond Figure 4. This results in the formation of two identical fragments that contain the light chain and the VH and CH1 domains of the heavy chain.

Antigen binding - These fragments were called the Fab fragments because they contained the antigen binding sites of the antibody. Each Fab fragment is monovalent whereas the original molecule was divalent. The combining site of the antibody is created by both VH and VL. An antibody is able to bind a particular antigenic determinant because it has a particular combination of VH and VL. Different combinations of a VH and VL result in antibodies that can bind a different antigenic determinants.

B. Fc
Digestion with papain also produces a fragment that contains the remainder of the two heavy chains each containing a CH2 and CH3 domain. This fragment was called Fc because it was easily crystallized.

 

stru-4.jpg (114225 bytes) Figure 4  Immunoglobulin fragments: Structure/function relationships

Effector functions - The effector functions of immunoglobulins are mediated by this part of the molecule. Different functions are mediated by the different domains in this fragment (Figure 5). Normally the ability of an antibody to carry out an effector function requires the prior binding of an antigen; however, there are exceptions to this rule.

stru-5.jpg (105512 bytes) Figure 5   Immunoglobulin fragments: Structure function relationships

C. F(ab')2
Treatment of immunoglobulins with pepsin results in cleavage of the heavy chain after the H-H inter-chain disulfide bonds resulting in a fragment that contains both antigen binding sites (Figure 6). This fragment was called F(ab')2 because it was divalent. The Fc region of the molecule is digested into small peptides by pepsin. The F(ab')2 binds antigen but it does not mediate the effector functions of antibodies.

 

stru-6.jpg (108870 bytes)  Figure  6   Immunoglobulin fragments: Structure/function relationships

continued to page -2



Please read the autoimmune E-Book for permanent treatment guidelines.

 


 

 

  

   World Wide Consultation by Internet

By pass heart surgery

Young Women Dying Of Heart Disease

Calcium

Trends in medicine 

Tremor

Top Foods

Ulcerative colitis 

Ultrasound

Fatty acids

                                  

 

IgA nepropathy

IgA nephropathy-2

IgA -3

911 CIDP story

Tetanus Vaccine Story

Stem Cell Story

Surgery CIDP

Cranial nerve CIDP

Farmer CIDP

Recurrent attack CIDP

Charcot

Car accident & CIDP

Arthritis & CIDP

Flu Shot Story

MS & CIDP story

Story21new

Renal transplant PRA

Neck Pain Tips

 

 

 Quran page